While reporting financial results for the first quarter on Thursday, medical technology company Becton, Dickinson and Co. or BD (BDX) lowered its adjusted earnings and revenue growth outlook for fiscal 2020, to reflect the impact of the remediation effort and anticipated loss of sales of the Alaris infusion system.
from RTT - Earnings https://ift.tt/2S2i6U9
via IFTTT
No comments:
Post a Comment